Literature DB >> 14613314

Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.

Yanping Xu1, Daniel Mayhugh, Ashraf Saeed, Xiaodong Wang, Richard C Thompson, Samuel J Dominianni, Raymond F Kauffman, Jaipal Singh, James S Bean, William R Bensch, Robert J Barr, John Osborne, Chahrzad Montrose-Rafizadeh, Richard W Zink, Nathan P Yumibe, Naijia Huang, Debra Luffer-Atlas, Deepa Rungta, Dale E Maise, Nathan B Mantlo.   

Abstract

A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the discovery of 5 (LY518674), a highly potent and selective PPARalpha agonist.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613314     DOI: 10.1021/jm034173l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

2.  Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist.

Authors:  Yan Shi; Jun Li; Lawrence J Kennedy; Shiwei Tao; Andrés S Hernández; Zhi Lai; Sean Chen; Henry Wong; Juliang Zhu; Ashok Trehan; Ngiap-Kie Lim; Huiping Zhang; Bang-Chi Chen; Kenneth T Locke; Kevin M O'Malley; Litao Zhang; Rai Ajit Srivastava; Bowman Miao; Daniel S Meyers; Hossain Monshizadegan; Debra Search; Denise Grimm; Rongan Zhang; Thomas Harrity; Lori K Kunselman; Michael Cap; Jodi Muckelbauer; Chiehying Chang; Stanley R Krystek; Yi-Xin Li; Vinayak Hosagrahara; Lisa Zhang; Pathanjali Kadiyala; Carrie Xu; Michael A Blanar; Robert Zahler; Ranjan Mukherjee; Peter T W Cheng; Joseph A Tino
Journal:  ACS Med Chem Lett       Date:  2016-04-04       Impact factor: 4.345

3.  Efficient access to sp3-rich tricyclic amine scaffolds through Diels-Alder reactions of azide-containing silyloxydienes.

Authors:  Michael C McLeod; Jeffrey Aubé
Journal:  Tetrahedron       Date:  2016-06-30       Impact factor: 2.457

4.  On the mechanism for PPAR agonists to enhance ABCA1 gene expression.

Authors:  Masaki Ogata; Maki Tsujita; Mohammad Anwar Hossain; Nobukatsu Akita; Frank J Gonzalez; Bart Staels; Shogo Suzuki; Tatsuya Fukutomi; Genjiro Kimura; Shinji Yokoyama
Journal:  Atherosclerosis       Date:  2009-01-19       Impact factor: 5.162

Review 5.  PPARs and the cardiovascular system.

Authors:  Milton Hamblin; Lin Chang; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

6.  Synthesis and biological activity of novel phenyltriazolinone derivatives.

Authors:  Qiongyou Wu; Guodong Wang; Shaowei Huang; Long Lin; Guangfu Yang
Journal:  Molecules       Date:  2010-12-09       Impact factor: 4.411

7.  Peroxisome proliferator-activated receptor alpha agonists regulate cholesterol ester transfer protein.

Authors:  Thomas P Beyer; Yanqun Chen; Regina K Porter; Deshun Lu; Robert J Schmidt; Nathan B Mantlo; Robert J Konrad; Guoqing Cao
Journal:  Lipids       Date:  2008-05-15       Impact factor: 1.646

Review 8.  Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.

Authors:  Virender Kumar; Xiaofei Xin; Jingyi Ma; Chalet Tan; Natalia Osna; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2021-07-24       Impact factor: 17.873

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.